Your browser doesn't support javascript.
loading
[Expert consensus on Tongsaimai Tablets/Capsules in treatment of peripheral vascular diseases in clinical practice].
Cao, Ye-Min; Wang, Yu-Zhen; Pei, Xiao-Hua; Yang, Bo-Hua; Zhao, Cheng; Fang, Yu-Dong; Que, Hua-Fa; Jiang, Yu-Feng; Xu, Xu-Ying; Xia, Cheng-Yong; Zhang, Jian-Qiang; He, Chun-Hong; Ma, Li-Ren.
Afiliação
  • Cao YM; Shanghai Integrated Traditional Chinese and Western Medicine Hospital Affiliated to Shanghai University of Traditional Chinese Medicine/Shanghai Institute of Integrated Traditional Chinese and Western Medicine and Vascular Diseases Shanghai 200086, China.
  • Wang YZ; Shanghai Integrated Traditional Chinese and Western Medicine Hospital Affiliated to Shanghai University of Traditional Chinese Medicine/Shanghai Institute of Integrated Traditional Chinese and Western Medicine and Vascular Diseases Shanghai 200086, China.
  • Pei XH; Xiamen Hospital of Beijing University of Chinese Medicine Xiamen 361001, China.
  • Yang BH; Dongzhimen Hospital, Beijing University of Chinese Medicine Beijing 100700, China.
  • Zhao C; Shanghai Integrated Traditional Chinese and Western Medicine Hospital Affiliated to Shanghai University of Traditional Chinese Medicine/Shanghai Institute of Integrated Traditional Chinese and Western Medicine and Vascular Diseases Shanghai 200086, China.
  • Fang YD; Shanghai Integrated Traditional Chinese and Western Medicine Hospital Affiliated to Shanghai University of Traditional Chinese Medicine/Shanghai Institute of Integrated Traditional Chinese and Western Medicine and Vascular Diseases Shanghai 200086, China.
  • Que HF; Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine Shanghai 200032, China.
  • Jiang YF; Special Medical Center of Strategic Support Force Beijing 100101, China.
  • Xu XY; Beijing Traditional Chinese Medicine Hospital Affiliated to Capital Medical University Beijing 100010, China.
  • Xia CY; Jiangsu Provincial Hospital of Traditional Chinese Medicine Nanjing 210004, China.
  • Zhang JQ; Shijiazhuang Hospital of Traditional Chinese Medicine Shijiazhuang 050051, China.
  • He CH; Luoyang Hospital of Traditional Chinese Medicine Luoyang 471000, China.
  • Ma LR; Pingdingshan Hospital of Traditional Chinese Medicine Pingdingshan 467000, China.
Zhongguo Zhong Yao Za Zhi ; 46(24): 6568-6573, 2021 Dec.
Article em Zh | MEDLINE | ID: mdl-34994150
ABSTRACT
Tongsaimai Tablets/Capsules are composed of Lonicerae Japonicae Flos, Angelicae Sinensis Radix, Achyranthis Bidentatae Radix, Codonopsis Radix, Dendrobii Caulis, Astragali Radix, Scrophulariae Radix, and Glycyrrhizae Radix et Rhizoma, and are effective in promoting blood circulation, removing blood stasis, supplementing Qi, and nourishing Yin. It is widely used in the treatment of peripheral vascular diseases. With 40 years of clinical application, it has accumulated substantial research data and application experience. Its good clinical efficacy and pharmacoeconomic benefits in improving the clinical symptoms of peripheral vascular diseases have been confirmed by relevant research. Meanwhile, this drug has also been recommended by many expert consensus, guidelines, and teaching materials, serving as one of the most commonly used Chinese patent medicines in clinical practice. To further improve the understanding of the drug among clinicians and properly guide its clinical medication, the China Association of Chinese Medicine took the lead and organized experts to jointly formulate this expert consensus. Based on the questionnaire survey of clinicians and the systematic review of research literature on Tongsaimai Tablets/Capsules with clinical problems in the PICO framework, the consensus, combined with expert experience, concludes recommendations or consensus suggestions by GRADE system with the optimal evidence available through the nominal group technique. This consensus defines the indications, usage, dosage, course of treatment, medication time, combined medication, and precautions of Tongsaimai Tablets/Capsules in the treatment of peripheral vascular diseases, and explains the safety of its clinical application. It is recommended for clinicians and pharmacists in the peripheral vascular department(vascular surgery), traditional Chinese medicine surgery(general surgery), and endocrinology department of hospitals at all levels in China.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Medicamentos de Ervas Chinesas / Doenças Vasculares Periféricas Tipo de estudo: Diagnostic_studies / Guideline / Qualitative_research Limite: Humans Idioma: Zh Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Medicamentos de Ervas Chinesas / Doenças Vasculares Periféricas Tipo de estudo: Diagnostic_studies / Guideline / Qualitative_research Limite: Humans Idioma: Zh Ano de publicação: 2021 Tipo de documento: Article